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Abstract
Background: Nonhuman primates (NHPs) are essential for biomedical research due to their
similarities to humans. The utility of NHPs will be greatly increased by the application of genomicsbased approaches such as gene expression profiling. Sequence information from the 3' end of genes
is the key resource needed to create oligonucleotide expression arrays.
Results: We have developed the algorithms and procedures necessary to quickly acquire sequence
information from the 3' end of nonhuman primate orthologs of human genes. To accomplish this,
we identified terminal exons of over 15,000 human genes by aligning mRNA sequences with
genomic sequence. We found the mean length of complete last exons to be approximately 1,400
bp, significantly longer than previous estimates. We designed primers to amplify genomic DNA,
which included at least 300 bp of the terminal exon. We cloned and sequenced the PCR products
representing over 5,500 Macaca mulatta (rhesus monkey) orthologs of human genes. This sequence
information has been used to select probes for rhesus gene expression profiling. We have also
tested 10 sets of primers with genomic DNA from Macaca fascicularis (Cynomolgus monkey),
Papio hamadryas (Baboon), and Chlorocebus aethiops (African green monkey, vervet). The results
indicate that the primers developed for this study will be useful for acquiring sequence from the 3'
end of genes for other nonhuman primate species.
Conclusion: This study demonstrates that human genomic DNA sequence can be leveraged to
obtain sequence from the 3' end of NHP orthologs and that this sequence can then be used to
generate NHP oligonucleotide microarrays. Affymetrix and Agilent used sequences obtained with
this approach in the design of their rhesus macaque oligonucleotide microarrays.
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Background
Gene expression profiling is expected to rapidly increase
the information yield from experiments using nonhuman
primates (NHPs). This is important because NHPs are
required for the study of AIDS, stem cell biology, reproduction and neuroscience, but are expensive and in short
supply [1-14].
One question which must be addressed is: given the close
evolutionary relationship between rhesus macaque and
humans, why not use available human oligonucleotide
microarrays with rhesus macaque samples? Human oligonucleotide microarrays have been used with chimpanzee
samples to obtain useful information [15-17]. Cross-species hybridization experiments utilizing rhesus samples
with human oligonucleotide microarrays have also been
attempted [15,18,19]. Although useful information has
been obtained, there are serious limitations to this
approach. Cross-species comparisons introduce mismatches between a probe and a transcript that are not
related to gene expression. Thus, it is impossible to know
if a weak or absent signal is due to low levels of expression
or to a mismatch. Approximately 40% of rhesus genes are
not detected with a human GeneChip [18,19]. For genes
that are scored present, the abundance of some transcripts
may be underestimated due to mismatches between some
of the human probes and rhesus targets. Longer probes
might be expected to be more forgiving of mismatches,
but even cDNA microarrays have a significant false negative rate when human microarrays are used with rhesus
samples [20]. Thus, the use of human micorarrays with
rhesus macaque samples results in a high rate of false negatives and does not allow for the acquisition of quantitative information. Clearly, a rhesus macaque specific
expression array is needed.
Construction of oligonucleotide-based microarrays
requires sequence from the 3' end of a transcript. There are
two reasons for this. First, most sample labeling protocols
are 3' biased [21,22]. As a result, probes chosen from
sequence more than 1 kb from the 3' end of a gene may
not detect a transcript. Second, it is important to choose
probes from the 3' untranslated region (UTR) because
such probes are most likely to be able to distinguish
between gene family members. This is because coding
sequences are much more highly conserved than 3' UTR
[23].
We report a fast and efficient approach to obtaining high
quality sequence of the 3' end NHP orthologs of human
genes. The terminal exons of 15,401 well-annotated
human genes were identified. Primer3 [24] was used to
design primers that amplified at least 300 bp of 3'
sequence. PCR was performed with these primers using
rhesus macaque genomic DNA as the template. PCR prod-
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ucts were cloned and sequenced. Over 5,300 rhesus
macaque gene sequences have been deposited in GenBank. These sequences were used in the creation of rhesus
macaque oligonucleotide microrarrays by two major companies, Affymetrix and Agilent. In addition, ten of the
primer pairs designed in the course of this project were
used with DNA obtained from three additional NHPs:
cynomolgus monkey (Macaca fascicularis), baboon (Papio
hamadryas), and African green monkey (Cercopithecus
aethiops).

Results
We found that at least 88% of human last exons were
greater than 300 bp in length (Fig. 1A). The mean length
for all last exons, including those that may be incomplete
on the 3' end was 1,398 bp (N = 15,401). The median
length was 1,003 bp. The shortest last exon in this group
was 24 bp; the longest was 18,174 bp. Because the 3' end
has not been determined for all transcripts, we also examined the lengths of complete last exons (N = 11,584; Fig.
1B). For these genes, the mean and median lengths were
1,414 bp and 1,046 bp, respectively. The shortest and
longest last exons in this group were 27 bp and 18,174 bp,
respectively. The last exon sequences we determined are
available as Additional files 1, 2, 3.
PCR was used to amplify rhesus macaque genomic DNA
using human primers. The PCR success rate (defined as
yielding a correct-sized band with, at most, a few minor
bands) with the first set of primers designed was 74%. If
the first set of primers failed to amplify, a second pair of
PCR primers was designed. The PCR success rate with the
second set of primers was 59%. Thus, with no more than
2 sets of human primers, 90% of the rhesus macaque
genes could be amplified. Only 2% of the PCR products
proved difficult to clone. We have deposited sequence
information for over 5,300 rhesus genes in the Sequence
Tagged Site database (dbSTS) at NCBI. These sequences
were used in the design of rhesus macaque oligonucleotide microarrays by Affymetrix and Agilent.
We chose ten primer sets that had worked successfully
with rhesus macaque DNA to determine whether the same
primer sets could be used with the genomic DNA of other
NHPs. These ten genes were chosen to represent a range of
identities between rhesus and human sequence – 91.21 to
98.57% identity (Table 1). The mean similarity between
these 10 rhesus and human sequences was 94.42%. All
PCRs performed with the 10 primers sets worked with
both cynomolgus monkey and baboon DNA. Nine of the
ten primer sets worked with vervet DNA. New primers
were designed for the one gene (IFNG) that did not work
with vervet DNA. The redesigned primers were successful
with vervet DNA. The mean similarity to human sequence
was about 94% for rhesus, cynomolgus monkey, baboon
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Last exon lengths. A) Lengths of human last exons (including incomplete exons). N = 15,401; mean = 1397.6; median = 1003;
standard deviation = 1257.3. The values on the abscissa are the upper lengths of the bins; e.g., the bar at 600 bp includes last
exons with lengths > 300 bp and ≤ 600 bp. The last bin – 8100 and marked with an asterisk (*) – contains last exons > 7800 bp
in length. B) Lengths of human last exons (complete exons only). N = 11,502; mean = 1414.9; median = 1048; standard deviation = 1255.3. Only last exons obtained from mRNA that was complete on the 3' end are included (see discussion in the text
for an explanation of how this was determined). The last bin – 8100 and marked with an asterisk (*) – contains all last exons
with lengths > 7800 bp.
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Table 1: Percent identity of 10 sequences obtained using the primers developed for this project with genomic DNA from rhesus
macaques, cynomologus monkeys, baboons and vervets.

% identity with rhesus
Baboon
Vervet

Gene

Cyno

IGF1
ESR1
IFNG
DGKI
RNF2
ADRBK2
IL15RA
TNF
IL16
TYK2

100
99.75
99.48
99.63
99.72
100
99.63
100
99.42
100

99.61
99.63
99.13
99.63
99.02
99.64
98.14
98.94
99.13
97.85

Mean

99.76

99.07

% identity with human
Baboon

Rhesus

Cyno

99.74
99.63
98.62
99.26
99.02
97.57
96.66
98.82
99.42
97.26

98.57
98.01
96.52
95.36
94.44
93.55
92.36
92.17
92.03
91.21

98.57
98.14
96
95.14
94.16
93.55
92.36
92.17
91.46
91.21

98.12
98.38
96.52
95.38
94.44
93.43
92.12
92.72
91.75
91.41

98.57
98.01
96.17
94.87
94.85
92.47
90.15
92.72
92.03
91.6

98.6

94.42

94.28

94.43

94.14

and vervet sequences. We also compared cynomolgus
monkey, baboon and vervet sequences with rhesus
sequences. Cynomolgus sequences were highly similar to
rhesus sequences: mean 99.76% identical, range 99.48 to
100% identical. Most baboon sequences were also highly
similar to rhesus sequences: mean 99.07% identical,
range 97.85 to 99.64% identical. The vervet sequences
were the least similar to rhesus sequences: mean 98.60%
identical, range 97.26 to 99.74% identical.

Discussion
Last exons
Our use of genomic DNA as a template for targeted PCR is
critically dependent on last exon length. At least 300 bp of
sequence is preferred for the design of oligonucleotide
probes present in oligonucleotide microarrays available
from Affymetrix [25]. Because at least 88% of all human
genes have last exons greater than 300 bp, for most genes,
genomic DNA can be used as the PCR template for obtaining 3' sequence.

Our calculated mean and median lengths for all human
last exons, 1,398 and 1,003, respectively are considerably
longer than previous reports of last exon length [26-28],
the longest mean of which was 811 bp. The procedures
used to determine the lengths of last exons in these studies
are not clear though most likely were based on aligning
mRNA sequence with genomic sequence as done here.
One possible reason for the longer last exons observed in
the current study is that the sequence data necessary to
determine the true 3'-end of many transcripts has become
available only recently. Our results are based on the use of
RefSeq Release 11 and GenBank Build 147, both obtained
from NCBI on 23 May 2005; other reports are based on

Vervet

earlier versions of the genome when less 3' information
was available. Although many of the transcripts in this
release of RefSeq are annotated as being complete on the
3' end, we increased the number of complete transcripts
by extending them as far as possible in the 3' direction by
using additional mRNA sequences. An increase in the
number of complete transcripts would obviously result in
an increase in the mean last exon length. This is supported
by the fact that when we considered only genes for which
a 3' end was present, the mean and median values
increased.
Use of STS primers for other NHP species
Our results suggest that the primers developed for this
project will be useful for obtaining sequence information
from the 3' end of genes of other NHP species. Further,
given that the rhesus and cynomolgus sequences were
very similar, we predict that oligonucleotide microarrays
designed based on rhesus sequence will work very well
with cynomolgus samples. Baboon samples should also
work well with rhesus oligonucleotide microarrays for
most genes. Vervet sequences for some genes are more
divergent from rhesus than cynomolgus monkey or
baboon, as would be expected based on evolutionary relationships. Thus, the false negative detection rate observed
with vervet samples on a rhesus oligonucleotide microarray may be significant and a targeted approach to obtaining 3' gene sequence from the vervet using primers
developed for this project may be justified.

Conclusion
This study demonstrates that human genomic DNA
sequence can be leveraged to obtain sequence from the 3'
end of NHP orthologs and that this sequence can then be
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Flowchart demonstrating the process used to obtain primer
pairs for the amplification of NHP orthologs of human genes.

used to generate NHP oligonucleotide microarrays.
Affymetrix and Agilent used sequences obtained with this
approach in the design of their rhesus macaque oligonucleotide microarrays.

Methods
Figure 2 illustrates the project flow for generating PCR
primers. A more complete overview is presented in Additional file 4.
Determination of last exons
Human mRNA reference sequences (RefSeq; Release 11)
were obtained from NCBI [29]. Sequences corresponding
to non-protein coding, withdrawn, hypothetical or pseudogenes in the LocusLink template database [30] were
removed. To create a non-redundant dataset of mRNAs,
only the longest RefSeq per gene was retained. After these
operations, our dataset contained a total of 15,663 unique
transcripts; accession numbers for these sequences are
available in Additional file 5.

Because 3' sequence is used to select probes, we aligned
(BLAST) RefSeqs with all human mRNA sequences from
the GenBank Primate (PRI) and high-throughput cDNA

sequencing (HTC) division to extend the 3' end of the
transcripts as far as possible. A given RefSeq was extended
with the mRNA sequence that: 1. had at least 300 bp of
alignment with the 3' end of the RefSeq; 2. had at least
98% identity with the RefSeq in the region of alignment;
and 3. extended the RefSeq the furthest in the 3' direction.
The extended mRNA sequences obtained above were
aligned with genomic DNA sequences from the phase 2
and 3 Human Genome Project sequence databases [31].
The approximate boundaries of exons can be determined
by examining High Scoring Pairs (HSP) from the alignment. Because HSPs only deviate from true exons by a few
nucleotides (due to ambiguity in the alignment at the
splice site), we defined the last exon as the 3'-most HSP.
Both last exons and flanking sequences were recorded. We
were unable to determine the last exon for 367 genes.
Determination of completeness
The 3' end has not been determined for all transcripts. To
calculate accurate statistics regarding last exon length, it is
important to work with a dataset that contains complete
last exons; this requires knowledge of which transcripts
are complete on the 3' end. To determine whether transcripts were complete on the 3' end, we used two strategies. First, we examined the complete GenBank FlatFile
records of the RefSeqs. Transcripts were considered complete on the 3' end if: 1. the Comment field contained the
phrase: "COMPLETENESS: full length" or "COMPLETENESS: complete on the 3' end"; or 2. the Feature table contained the keys "polyA_signal" or "polyA_site". Second,
because not all complete transcripts have been annotated
as such in GenBank, we also aligned the 3' end of the
extended mRNA sequence with genomic sequence
(hs_phase3). If three or more "A"s were found on the 3'
end of the transcript that were not present in the corresponding genomic sequence, we assumed that this indicated a poly-A tail was present in the extended mRNA
sequence and that therefore the transcript was complete
on the 3' end. We defined full length last exons as those
derived from mRNA sequences that were complete on the
3' end.
Primer selection procedure
Affymetrix has identified Probe Selection Regions in the 3'
ends of transcripts which are frequently contained within
the last exon of genes. We aligned (BLAST) the last exons
with the Probe Selection Regions. If there was at least 300
bp of alignment between the Probe Selection Region and
the last exon, Primer3 [24] was used to select primers that
flanked the Probe Selection Region (Figure 3). If not,
Primer3 was used to amplify at least 300 bp of sequence
from the last exon. The Human Mispriming library was
selected; when this option is chosen, Primer3 screens out

Page 5 of 8
(page number not for citation purposes)

BMC Genomics 2005, 6:160

http://www.biomedcentral.com/1471-2164/6/160
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fp PSR rp
Diagram
Figure 3illustrating the strategy for designing primers to amplify 3' sequence from NHP genes
Diagram illustrating the strategy for designing primers to amplify 3' sequence from NHP genes. Exons are indicated by boxes. Solid lines represent introns. The dashed line indicates sequence 3' to the 3' end of the gene. The poly-A signal
is indicated at the 3' end of the last exon. fp = forward primer; rp = reverse primer; PSR = probe selection region.

interspersed repeats from sequences which can be used for
primers.
Bioinformatics
Automation of the Determination of Last Exons and
Primer Selection procedures was accomplished with software written in Python and Java and employed packages
from the http://www.biojava.org site. An archived collection of Java methods used in determining last exons and
generating primer pairs is included as Additional file 6. A
complete description of the procedures used to determine
last exons and design primers can be found in Additional
file 7. A detailed description of the quality control procedures used to verify the results obtained for last exon
determination and primer design can be found in Additional file 8. Data was stored and organized in PostgreSQL
and Filemaker Pro databases. All primer sequences, PCR
conditions and sequences generated as a result of this
project have been deposited in GenBank (see Additional
file 9 for accession numbers).
PCR
Genomic DNA was isolated from the liver of a one year
old male rhesus macaque at the Oregon National Primate
Research Center. Primers were synthesized by SigmaGenosys (The Woodlands, TX) or IDT (Coralville, IA).
Primers were resuspended in RNAse/DNAase free water to
50 picomoles/µl. Primers were then aliquoted into 96well daughter plates with a Biomek 2000 robot (Beckman-Coulter). 10 µl of RNAse/DNAse free water, 1 µl of
forward and reverse primers at 50 picomoles/µl and 2 µl
of genomic DNA at 100 ng/µl were dispensed by the robot
into each well of a 96-well PCR plate (MJ Research). A
mastermix was prepared that included PCR buffer, dNTPs
and water and was dispensed into each PCR well such that

the final concentration was 1× PCR buffer and 200 µM
dNTPs. 0.5 µl (2.5 units) of Fast Start High Fidelity
Polymerase (Roche) was then added to each well. The
PCR plate was placed in a MJ Research PTC-100 thermocycler and the following program used: Step 1. 95°C for 2
minutes; Step 2. 95°C for 30 sec, 51°C for 30 sec, 72°C
for 1 min, 35 cycles; Step 3. 72°C for 7 minutes. For the
primers that failed the first PCR, PCR conditions were
altered. If the first PCR resulted in no band, the annealing
temperature was decreased to 48°C. If the first PCR
resulted in multiple bands, the annealing temperature was
increased to 53°C. All PCR cleanups were done using the
QIAquick 96-Multiwell PCR Purification System (Qiagen).
Cloning and DNA purification
Most PCR products were cloned into pGEM-T Easy
(Promega). Some PCR products were cloned into pCRTOPO XL (Invitrogen). After transformation, cells were
incubated in SOC medium for 2 hours at 37°C at 180
RPM. 50 µl of the cell suspension was added to 35 mm LBagar plates and incubated overnight at 37°C. Clones were
picked and grown in 2xTY growth media and incubated
overnight at 37°C at 300 RPM. Plasmid DNA was purified
using the QIAprep 96 Turbo Miniprep Kit (Qiagen).
Sequencing and Genbank deposits
All clones were sequenced in both directions on an
ABI3130 Genetic Analyzer using m13 forward and reverse
primers. Sequences were aligned, edited in Sequencher
(Gene Codes Corporation, Ann Arbor, MI) and BLASTed
to check identity and percent homology with the targeted
human homolog. The human primers were deleted from
the edited sequence and the edited sequence deposited in
GenBank following the standard STS format. STS files
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were generated from a Filemaker Pro database using the
Troi File Plug-in . A list of accession numbers is provided
as Additional file 9.
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Website Reference
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Additional material
Additional File 1
Last exon sequences (Part 1). FASTA-formatted files containing the last
exons of 15,401 unique human genes. XML-styles tags in the header are
used to denote the LocusLink ID (now GeneID) and symbol of the corresponding gene. The tags <baseAccNo> and <extAccNo> denote the accession number of the base reference sequence and mRNA sequence,
respectively, used to generate the extended mRNA sequence from which
the last exon was derived.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712164-6-160-S1.fna]

Additional File 2
Last exon sequences (Parts 2). FASTA-formatted files containing the last
exons of 15,401 unique human genes. XML-styles tags in the header are
used to denote the LocusLink ID (now GeneID) and symbol of the corresponding gene. The tags <baseAccNo> and <extAccNo> denote the accession number of the base reference sequence and mRNA sequence,
respectively, used to generate the extended mRNA sequence from which
the last exon was derived.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712164-6-160-S2.fna]
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Additional File 3
Last exon sequences (Parts 3). FASTA-formatted files containing the last
exons of 15,401 unique human genes. XML-styles tags in the header are
used to denote the LocusLink ID (now GeneID) and symbol of the corresponding gene. The tags <baseAccNo> and <extAccNo> denote the accession number of the base reference sequence and mRNA sequence,
respectively, used to generate the extended mRNA sequence from which
the last exon was derived.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712164-6-160-S3.fna]

Additional File 4
Procedure Flowchart. Provides a detailed overview of the procedure used
to obtain primer pairs for the amplification of NHP orthologs of human
genes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712164-6-160-S4.pdf]

Additional File 5
Accession numbers of Unique Reference Sequences (with LocusLink ID,
now GeneID, and Gene Symbol). List of accession numbers of the 15,633
unique human mRNA Reference Sequences used to generate the human
last exons in this study; includes the associated LocusLink ID (2nd column)
and gene symbol (3rd column) for each sequence.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712164-6-160-S5.tab]

Additional File 6
Java methods. An archived collection of Java methods used in determining
last exons and generating primer pairs. Used in conjuction with bioJava
1.30 (also included). See the file BlastObjectParser.java for a brief explanation on usage of the various processing methods.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712164-6-160-S6.gz]

Additional File 7
Detailed Methods. Contains the complete procedures used to determine
last exons and generate primer pairs. Details left out for brevity in the
main text are provided here.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712164-6-160-S7.pdf]

Additional File 8
Quality control. Provides a detailed description of the quality control
measures employed when generating last exons and primer pairs.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712164-6-160-S8.pdf]

Additional File 9
List of STS Accession Numbers. List of GenBank accession numbers of the
STS sequences generated in this study.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712164-6-160-S9.txt]
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